Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.

Tumori(2023)

引用 0|浏览3
暂无评分
摘要
Our study indicated that ESCC patients with the presence of TLS had better outcomes and an inflamed immune microenvironment. In addition, both TLS-9 and TLS-12 gene signatures could be used as potential biomarkers for the immunotherapy of ESCC patients.
更多
查看译文
关键词
ESCC, TLS, prognosis, immunotherapy, TLS gene-related signatures
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要